Marvel Biosciences Corp. (MRVL.V)
0.18
+0.02
(+9.09%)
CAD |
TSXV |
Apr 02, 16:00
Marvel Biosciences EPS Diluted (Quarterly) : -0.0051 for Jan. 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arch Biopartners, Inc. | -0.0236 |
| Aptose Biosciences, Inc. | -4.239 |
| MedMira, Inc. | -0.0009 |
| Innovotech, Inc. | 0.0032 |
| Entheon Biomedical Corp. | -0.0048 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.2956M |
| Total Expenses (Quarterly) | 0.2956M |
| Enterprise Value | 12.48M |
| Earnings Yield | -21.83% |
| Normalized Earnings Yield | -17.39 |